Cargando…
Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512449/ http://dx.doi.org/10.7448/IAS.15.6.18079 |
_version_ | 1782251728514580480 |
---|---|
author | Lamorde, M |
author_facet | Lamorde, M |
author_sort | Lamorde, M |
collection | PubMed |
description | Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of an HIV Research Trust scholarship recipient in Uganda. The work highlights the need for post-marketing pharmacokinetic studies in the target populations in order to optimize therapy for patients in resource-limited settings. |
format | Online Article Text |
id | pubmed-3512449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-35124492012-12-03 Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients Lamorde, M J Int AIDS Soc Oral Abstract – O141 Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of an HIV Research Trust scholarship recipient in Uganda. The work highlights the need for post-marketing pharmacokinetic studies in the target populations in order to optimize therapy for patients in resource-limited settings. International AIDS Society 2012-11-11 /pmc/articles/PMC3512449/ http://dx.doi.org/10.7448/IAS.15.6.18079 Text en © 2012 Lamorde M. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Abstract – O141 Lamorde, M Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title | Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title_full | Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title_fullStr | Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title_full_unstemmed | Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title_short | Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients |
title_sort | clinical pharmacokinetics of antiretroviral drugs in ugandan patients |
topic | Oral Abstract – O141 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512449/ http://dx.doi.org/10.7448/IAS.15.6.18079 |
work_keys_str_mv | AT lamordem clinicalpharmacokineticsofantiretroviraldrugsinugandanpatients |